SCHEMBL517339

SCHEMBL517339

CCN(CC)[N+]([O-])=NO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL517340 1.00
SCHEMBL819207 1.00
SCHEMBL517338 1.00
SCHEMBL1525454 0.97 ALOX15 (0.74)
SCHEMBL29394097 0.97 ALOX15 (0.74)
SCHEMBL1374556 0.97 ALOX15 (0.74)
SCHEMBL8089487 0.97 ALOX15 (0.74)
Diethylamine SCHEMBL1524932 0.88 ALOX15 (1.00)
Diethylamine SCHEMBL1524933 0.88 ALOX15 (1.00)
Diethylamine SCHEMBL447262 0.88 ALOX15 (1.00)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 346 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3338813-B2 MULTI-LAYER WOUND CARE PRODUCT WITH PERFORATED RELEASE LAYER BSN MEDICAL GMBH (DE) 2026-04-15 EP claimed
EP-3558399-B2 MULTI-LAYER WOUND CARE PRODUCT WITH PERFORATED RELEASE LAYER BSN MEDICAL GMBH (DE) 2026-01-14 EP claimed
EP-3842076-B1 MULTI-LAYER WOUND CARE PRODUCT WITH PERFORATED RELEASE LAYER BSN MEDICAL GMBH (DE) 2023-02-15 EP claimed
EP-3842076-A1 MULTI-LAYER WOUND CARE PRODUCT WITH PERFORATED RELEASE LAYER BSN medical GmbH (DE) 2021-06-30 EP claimed
EP-3558399-B1 MULTI-LAYER WOUND CARE PRODUCT WITH PERFORATED RELEASE LAYER BSN MEDICAL GMBH (DE) 2021-01-20 EP claimed
EP-3338813-B1 MULTI-LAYER WOUND CARE PRODUCT WITH PERFORATED RELEASE LAYER BSN MEDICAL GMBH (DE) 2020-01-29 EP claimed
US-20190328926-A1 MULTI-LAYER WOUND CARE PRODUCT WITH PERFORATED RELEASE LAYER BSN MEDICAL GMBH (DE) 2019-10-31 US claimed
EP-3558399-A1 MULTI-LAYER WOUND CARE PRODUCT WITH PERFORATED RELEASE LAYER BSN medical GmbH (DE) 2019-10-30 EP claimed
WO-2018114871-A1 MULTI-LAYER WOUND CARE PRODUCT WITH PERFORATED RELEASE LAYER BSN MEDICAL GMBH (DE) 2018-06-28 WO claimed
EP-3338813-A1 MULTI-LAYER WOUND CARE PRODUCT WITH PERFORATED RELEASE LAYER BSN Medical GmbH (DE) 2018-06-27 EP claimed
WO-2008098192-A2 COMPOSITIONS AND METHODS FOR TREATING NEUROPATHY MAIBACH TODD (US) 2008-08-14 WO claimed
WO-2008080194-A1 PAIN-RELIEVING COMPOSITIONS AND USES THEREFOR THE UNIVERSITY OF QUEENSLAND (AU) 2008-07-10 WO claimed
WO-2007100910-A2 TRANSDERMAL PATCHES CONTAINING A NITRIC OXIDE-DONOR AND A SECOND ACTIVE AGENT AND ASSOCIATED METHODS CURE THERAPEUTICS, INC. (US) 2007-09-07 WO claimed
US-20070202155-A1 Low dose no donor-containing transdermal patch CURE THERAPEUTICS, INC. 2007-08-30 US claimed
WO-2007092284-A2 LOW DOSE NO DONOR-CONTAINING TRANSDERMAL PATCH CURE THERAPEUCTICS, INC. (US) 2007-08-16 WO claimed
US-20070059351-A1 Transdermal patches containing a nitric oxide-donor and a second active agent and associated methods CURE THERAPEUTICS, INC. 2007-03-15 US claimed
US-20030215528-A1 Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype QUEENS UNIVERSITY AT KINGSTON (CA) 2003-11-20 US claimed
US-6586478-B2 Administering nitrogen oxide mimetic CELLEGY CANADA (CA) 2003-07-01 US claimed
US-6306841-B1 NITROVASODILATOR SELECTED FROM SODIUM NITROPRUSSIDE, DIAZENIUM DIOLATE MOLSIDOMINE, LINSIDOMINE CHLORHYDRATE, S-NITROSOTHIOLS, ORGANIC NITRATES, PHARMACOLOGICALLY ACCEPTABLE SALTS, ASIVI, LLC 2001-10-23 US claimed
US-6266560-B1 Electrically assisted transdermal method and apparatus for the treatment of erectile dysfunction GENETRONICS, INC. 2001-07-24 US claimed